Day: March 3, 2022

Helsinn Group and BridgeBio Pharma Announce Update to Strategic Collaboration to Develop, Manufacture and Commercialize Infigratinib in Oncology Indications in the U.S.

Helsinn Group and BridgeBio Pharma Announce Update to Strategic Collaboration to Develop, Manufacture and Commercialize Infigratinib in Oncology Indications in the U.S. Helsinn gains an exclusive license to commercialize infigratinib in the U.S. Lugano, Switzerland and Palo Alto, CA, March 3, 2022 – Helsinn Group (Helsinn), a fully integrated, global biopharma

Read More

U.S. Polo Assn. Launches Spring 2022 Collection

Iconic, Sport-Inspired Brand Celebrates Spring with Sun-Washed Pastels, Florals, and Tropical Prints U.S. Polo Assn. WEST PALM BEACH, Fla., March 03, 2022 (GLOBE NEWSWIRE) — U.S. Polo Assn., the official brand of the United States Polo Association (USPA), has launched its

Read More

GA-ASI Introduces Gambit

New Autonomous Collaborative Platform Designed to Lead From Front Featured Image for General Atomics Aeronautical Systems Inc. SAN DIEGO, March 03, 2022 (GLOBE NEWSWIRE) — General Atomics Aeronautical Systems, Inc. (GA-ASI), the world leader in unmanned aircraft and associated technologies,

Read More